Deal Library / Pharma BD Deal Intelligence
The Pharma Closeout tracks 4 deals, $7.1B in disclosed deal value, 3 with a post-close Outcome Score for Boston Scientific Corporation.
Median Critic Score: 84 · Median Outcome Score: 78
Best outcome: Boston Scientific Corporation / Endo International plc (American Medical Systems Men's Health and Prostate Health) (82) · Weakest outcome: Boston Scientific Corporation / Advanced Bionics Corporation (26)